← SynDRA
DIGITOXIGENIN
SynDRA canonical compound SYN0007299 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ATP1A1 |
|---|
| Mechanism of action | ATPase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ATPase inhibitor
- ATP1A1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ATP12A
- ATAD5
- CBX1
- EHMT2
- GLP1R
- GMNN
- HDAC6
- IDH1
- NFE2L2
- NPC1
- PAX8
- RAB9A
- SMAD3
- TDP1
- TSHR
- UGT1A4
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT5A
- GALR3
- OPRM
- OPRD
- NR5A2
- NCOA3
- NCOA1
- MITF
- MDR1
- MDM4
- MDM2
- IFNG
- IDHC
- HIF1A
- FXYD2
- ATP1A2
- EPAS1
- CSTA
- COT2
- CFTR
- BRCA1
- BARD1
- ATXN2
- ATP1B3
- ATP1B2
- ATP1B1
- ATP1A4
- ATP1A3
- STK33
Cross-references
Synonyms
- Digoxigenin
- Uzarigenin
- UNII-K9ZR7LI283
- EINECS 207-373-0
- NSC 119993
- BRN 0095446
- K9ZR7LI283
- 3-beta-14-beta-5-Allo-cardenolid [German]
- 3beta,14-Dihydroxy-5alpha-card-20(22)-enolide
- 3-beta,14-Dihydroxy-5-alpha-card-20(22)-enolide
- 4-18-00-01470 (Beilstein Handbook Reference)
- Urarigenin
- Odorigeni
- 3-beta-14-beta-5-Allo-cardenolid
- AC1L3OS7
- CHEMBL109863
- SCHEMBL1152953
- XZTUSOXSLKTKJQ-CIXPXFMPSA-N
- MolPort-006-111-351
- ZINC4073972
- MCULE-2541512222
- NCGC00384854-01
- BC271971
- 3,14-Dihydroxycard-20(22)-enolide #
- Cerberigenin
- Echujetin
- Thevetigenin
- Evonogenin
- Digitoxigenine
- 3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
- S63WOD4VOL
- NSC-407806
- MLS002153810
- CHEBI:42219
- 3beta,14-Dihydroxy-5beta-card-20(22)-enolide
- SMR001233182
- 3-beta,14beta-dihydroxy-5-beta-card-20(22)-enolide
Look up DIGITOXIGENIN in the interactive SynDRA portal →